About

Publications While At Healthpartners

selected publications

Journal Article

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. 

Neuro-Oncology. 2023

Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. 

Journal of Neurosurgery. 2022

Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial. 

Cardiovascular Diabetology. 2012

Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants. 

Diabetic Medicine. 2012

Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. 

Diabetes care. 2011

Review

Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force [review, systematic review]. 

Annals of Internal Medicine. 2015

Abstract

Long-term impact of intensive glucose, blood pressure, or lipid control on health utility: ACCORDION Study [abstract]. 

Diabetes. 2016

Costs associated with delivering intensive or standard glucose, lipids, and systolic blood pressure control strategies in the ACCORD Trial [abstract]. 

Diabetes. 2013

Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract]. 

Diabetes. 2012

Contact

full name

P. Zhang

Quick Info

 

Collaboration

Co-author network

Map of science